Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions
Identifieur interne : 003397 ( Pmc/Curation ); précédent : 003396; suivant : 003398Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions
Auteurs : Jessica F. Yang ; Amit Walia ; Yu-Hui Huang ; Kyu-Yeon Han ; Mark I. Rosenblatt ; Dimitri T. Azar ; Jin-Hong ChangSource :
- Survey of ophthalmology [ 0039-6257 ] ; 2015.
Abstract
A major focus of cancer research for several decades has been understanding the ability of tumors to induce new blood vessel formation, a process known as angiogenesis. Unfortunately, only limited success has been achieved in the clinical application of angiogenesis inhibitors. We now know that lymphangiogenesis, the growth of lymphatic vessels, likely also plays a major role in tumor progression. Thus, therapeutic strategies targeting lymphangiogenesis or both lymphangiogenesis and angiogenesis may represent promising approaches for treating cancer and other diseases. Importantly, research progress toward understanding lymphangiogenesis is significantly behind that related to angiogenesis. A PubMed search of ‘angiogenesis’ returns nearly 80,000 articles, whereas a search of ‘lymphangiogenesis’ returns approximately 2,635 articles. This stark contrast can be explained by the lack of molecular markers for identifying the invisible lymphatic vasculature that persisted until less than two decades ago combined with the intensity of research interest in angiogenesis during the past half-century. Still, significant strides have been made in developing strategies to modulate lymphangiogenesis, largely using ocular disease models. Here, we review the current knowledge of lymphangiogenesis in the context of knockout models, ocular diseases, the biology of activators and inhibitors, and the potential for therapeutic interventions targeting this process.
Url:
DOI: 10.1016/j.survophthal.2015.12.004
PubMed: 26706194
PubMed Central: 4835265
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003398
Links to Exploration step
PMC:4835265Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions</title>
<author><name sortKey="Yang, Jessica F" sort="Yang, Jessica F" uniqKey="Yang J" first="Jessica F." last="Yang">Jessica F. Yang</name>
</author>
<author><name sortKey="Walia, Amit" sort="Walia, Amit" uniqKey="Walia A" first="Amit" last="Walia">Amit Walia</name>
</author>
<author><name sortKey="Huang, Yu Hui" sort="Huang, Yu Hui" uniqKey="Huang Y" first="Yu-Hui" last="Huang">Yu-Hui Huang</name>
</author>
<author><name sortKey="Han, Kyu Yeon" sort="Han, Kyu Yeon" uniqKey="Han K" first="Kyu-Yeon" last="Han">Kyu-Yeon Han</name>
</author>
<author><name sortKey="Rosenblatt, Mark I" sort="Rosenblatt, Mark I" uniqKey="Rosenblatt M" first="Mark I" last="Rosenblatt">Mark I. Rosenblatt</name>
</author>
<author><name sortKey="Azar, Dimitri T" sort="Azar, Dimitri T" uniqKey="Azar D" first="Dimitri T." last="Azar">Dimitri T. Azar</name>
</author>
<author><name sortKey="Chang, Jin Hong" sort="Chang, Jin Hong" uniqKey="Chang J" first="Jin-Hong" last="Chang">Jin-Hong Chang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26706194</idno>
<idno type="pmc">4835265</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835265</idno>
<idno type="RBID">PMC:4835265</idno>
<idno type="doi">10.1016/j.survophthal.2015.12.004</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">003398</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003398</idno>
<idno type="wicri:Area/Pmc/Curation">003397</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003397</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions</title>
<author><name sortKey="Yang, Jessica F" sort="Yang, Jessica F" uniqKey="Yang J" first="Jessica F." last="Yang">Jessica F. Yang</name>
</author>
<author><name sortKey="Walia, Amit" sort="Walia, Amit" uniqKey="Walia A" first="Amit" last="Walia">Amit Walia</name>
</author>
<author><name sortKey="Huang, Yu Hui" sort="Huang, Yu Hui" uniqKey="Huang Y" first="Yu-Hui" last="Huang">Yu-Hui Huang</name>
</author>
<author><name sortKey="Han, Kyu Yeon" sort="Han, Kyu Yeon" uniqKey="Han K" first="Kyu-Yeon" last="Han">Kyu-Yeon Han</name>
</author>
<author><name sortKey="Rosenblatt, Mark I" sort="Rosenblatt, Mark I" uniqKey="Rosenblatt M" first="Mark I" last="Rosenblatt">Mark I. Rosenblatt</name>
</author>
<author><name sortKey="Azar, Dimitri T" sort="Azar, Dimitri T" uniqKey="Azar D" first="Dimitri T." last="Azar">Dimitri T. Azar</name>
</author>
<author><name sortKey="Chang, Jin Hong" sort="Chang, Jin Hong" uniqKey="Chang J" first="Jin-Hong" last="Chang">Jin-Hong Chang</name>
</author>
</analytic>
<series><title level="j">Survey of ophthalmology</title>
<idno type="ISSN">0039-6257</idno>
<idno type="eISSN">1879-3304</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P2">A major focus of cancer research for several decades has been understanding the ability of tumors to induce new blood vessel formation, a process known as angiogenesis. Unfortunately, only limited success has been achieved in the clinical application of angiogenesis inhibitors. We now know that lymphangiogenesis, the growth of lymphatic vessels, likely also plays a major role in tumor progression. Thus, therapeutic strategies targeting lymphangiogenesis or both lymphangiogenesis and angiogenesis may represent promising approaches for treating cancer and other diseases. Importantly, research progress toward understanding lymphangiogenesis is significantly behind that related to angiogenesis. A PubMed search of ‘angiogenesis’ returns nearly 80,000 articles, whereas a search of ‘lymphangiogenesis’ returns approximately 2,635 articles. This stark contrast can be explained by the lack of molecular markers for identifying the invisible lymphatic vasculature that persisted until less than two decades ago combined with the intensity of research interest in angiogenesis during the past half-century. Still, significant strides have been made in developing strategies to modulate lymphangiogenesis, largely using ocular disease models. Here, we review the current knowledge of lymphangiogenesis in the context of knockout models, ocular diseases, the biology of activators and inhibitors, and the potential for therapeutic interventions targeting this process.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0404551</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7667</journal-id>
<journal-id journal-id-type="nlm-ta">Surv Ophthalmol</journal-id>
<journal-id journal-id-type="iso-abbrev">Surv Ophthalmol</journal-id>
<journal-title-group><journal-title>Survey of ophthalmology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0039-6257</issn>
<issn pub-type="epub">1879-3304</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">26706194</article-id>
<article-id pub-id-type="pmc">4835265</article-id>
<article-id pub-id-type="doi">10.1016/j.survophthal.2015.12.004</article-id>
<article-id pub-id-type="manuscript">NIHMS745798</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Yang</surname>
<given-names>Jessica F.</given-names>
</name>
<degrees>BS</degrees>
<xref rid="FN2" ref-type="author-notes">†</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Walia</surname>
<given-names>Amit</given-names>
</name>
<degrees>BS</degrees>
<xref rid="FN2" ref-type="author-notes">†</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Huang</surname>
<given-names>Yu-hui</given-names>
</name>
<degrees>MS</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Han</surname>
<given-names>Kyu-yeon</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Rosenblatt</surname>
<given-names>Mark I</given-names>
</name>
<degrees>MD, PhD, MBA</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Azar</surname>
<given-names>Dimitri T.</given-names>
</name>
<degrees>MD, MBA</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Chang</surname>
<given-names>Jin-Hong</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
<aff id="A1">Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois</aff>
</contrib-group>
<author-notes><corresp id="FN1"><label>*</label>
Corresponding author: Jin-Hong Chang, PhD, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, 1855 West Taylor Street, Chicago, IL 60612, USA, Phone: (312) 413-5590, Fax: (312) 996-7770, (<email>changr@uic.edu</email>
)</corresp>
<fn id="FN2" fn-type="equal"><label>†</label>
<p><bold>Author Contribution</bold>
</p>
<p>J.F.Y. and A.W. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>18</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub"><day>17</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><season>May-Jun</season>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>61</volume>
<issue>3</issue>
<fpage>272</fpage>
<lpage>296</lpage>
<pmc-comment>elocation-id from pubmed: 10.1016/j.survophthal.2015.12.004</pmc-comment>
<abstract><p id="P2">A major focus of cancer research for several decades has been understanding the ability of tumors to induce new blood vessel formation, a process known as angiogenesis. Unfortunately, only limited success has been achieved in the clinical application of angiogenesis inhibitors. We now know that lymphangiogenesis, the growth of lymphatic vessels, likely also plays a major role in tumor progression. Thus, therapeutic strategies targeting lymphangiogenesis or both lymphangiogenesis and angiogenesis may represent promising approaches for treating cancer and other diseases. Importantly, research progress toward understanding lymphangiogenesis is significantly behind that related to angiogenesis. A PubMed search of ‘angiogenesis’ returns nearly 80,000 articles, whereas a search of ‘lymphangiogenesis’ returns approximately 2,635 articles. This stark contrast can be explained by the lack of molecular markers for identifying the invisible lymphatic vasculature that persisted until less than two decades ago combined with the intensity of research interest in angiogenesis during the past half-century. Still, significant strides have been made in developing strategies to modulate lymphangiogenesis, largely using ocular disease models. Here, we review the current knowledge of lymphangiogenesis in the context of knockout models, ocular diseases, the biology of activators and inhibitors, and the potential for therapeutic interventions targeting this process.</p>
</abstract>
<kwd-group><kwd>VEGF-C</kwd>
<kwd>VEGFR-3</kwd>
<kwd>LYVE-1</kwd>
<kwd>prox-1</kwd>
<kwd>podoplanin</kwd>
<kwd>dry eye disease</kwd>
<kwd>corneal transplant</kwd>
<kwd>herpetic stromal keratitis</kwd>
<kwd>glaucoma</kwd>
<kwd>ocular tumor</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003397 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 003397 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:4835265 |texte= Understanding Lymphangiogenesis in Knockout Models, the Cornea, and Ocular Diseases for the Development of Therapeutic Interventions }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:26706194" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |